HemaSphere (Jun 2022)

S300: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD)

  • M. D’Agostino,
  • S. Bringhen,
  • R. Ria,
  • F. Ciceri,
  • A. P. Falcone,
  • M. Michieli,
  • M. Grasso,
  • F. Pane,
  • M. Quaresima,
  • F. Cattel,
  • M. Mirabile,
  • F. Fioritoni,
  • M. T. Petrucci,
  • V. Cotugno,
  • A. Capra,
  • S. Pezzatti,
  • M. L. Mosca Siez,
  • M. Cantonetti,
  • G. Margiotta Casaluci,
  • P. Bertazzoni,
  • R. Floris,
  • M. Offidani,
  • G. Pietrantuono,
  • A. Evangelista,
  • M. Boccadoro,
  • A. Larocca

DOI
https://doi.org/10.1097/01.HS9.0000844092.71570.04
Journal volume & issue
Vol. 6
pp. 201 – 202

Abstract

Read online

No abstracts available.